Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Petitti: Update on the methods of the US Preventive Services Task Force: Insufficient evidence. (0.07 sec) 

[PDF] Update on the methods of the US Preventive Services Task Force: Insufficient …


DB Petitti, SM Teutsch, MB Barton, GF … - Annals of Internal …, 2009 - coloradoguidelines.org
The US Preventive Services Task Force (USPSTF) seeks to provide reliable and accurate
evidence-based recommendations to primary care clinicians. However, clinicians indicate frustration
with the lack of guidance provided by the USPSTF when the evidence is insuf- ficient to ...
Cited by 6 - Related articles - View as HTML - All 8 versions

[PDF] Melanoma Is Up: Are We Up to This Challenge?


KC Lee, MA Weinstock - Journal of Investigative …, 2009 - reseau-melanome-ouest.com
Linos and colleagues provide important evidence that the increasing incidence of melanoma
is not solely from increases in thin melanomas discovered by more intensive screening. This
underscores the inadequacy of primary prevention to date, and the importance of early ...
Cited by 1 - Related articles - View as HTML - All 3 versions

The Scientific Foundation for Personal Genomics: Recommendations from a …

- nursing2008.com
MJ Khoury, CM McBride, SD Schully, J Ioannidis, … - Genetics in …, 2009 - journals.lww.com
Muin J. Khoury, MD, PhD1,2, Colleen M. McBride, PhD3, Sheri D. Schully, PhD2, John PA
Ioannidis, MD, PhD4, W. Gregory Feero, MD, PhD3, A. Cecile JW Janssens, PhD5, Marta
Gwinn, MD, MPH1, Denise G. Simons-Morton, MD, PhD6, Jay M. Bernhardt, PhD7, ...
Cited by 2 - Related articles - All 7 versions

The Genomic Applications in Practice and Prevention Network


MJ Khoury, WG Feero, M Reyes, T Citrin, A Freedman, … - 2009 - pubmedcentral.nih.gov
The authors describe the rationale and initial development of a new collaborative initiative, the
Genomic Applications in Practice and Prevention Network. The network convened by the Centers
for Disease Control and Prevention and the National Institutes of Health includes multiple ...
Cited by 2 - Related articles - All 4 versions

Evaluating the utility of personal genomic information


MW Foster, JJ Mulvihill, RR Sharp - Genetics in Medicine, 2009 - journals.lww.com
Abstract: In evaluating the utility of human genome-wide assays, the answer will differ depending
on why the question is asked. For purposes of regulating medical tests, a restrictive sense of
clinical utility is used, although it may be possible to have clinical utility without changing ...
Cited by 3 - Related articles - All 4 versions

A health services research agenda for cellular, molecular and genomic …


L Wideroff, KA Phillips, G Randhawa, A Ambs, … - Public Health …, 2009 - content.karger.com
Background: In recent decades, extensive resources have been invested to develop cellular,
molecular and genomic technologies with clinical applications that span the continuum of cancer
care. Methods: In December 2006, the National Cancer Institute sponsored the first ...
Cited by 2 - Related articles - All 3 versions

Predictors of attrition and weight loss in an adolescent weight control program


E Jelalian, CN Hart, RS Mehlenbeck, EE Lloyd- … - Obesity, 2008 - nature.com
Higher parent (P < 0.01) and adolescent BMI (P < 0.05) at baseline, as well as ethnic minority
status (P < 0.05) were significantly associated with attrition in univariate analyses. Parent BMI
remained the only significant predictor of attrition in multivariate analyses. BMI change for ...
Cited by 2 - Related articles - All 3 versions

Demographic and Socioeconomic predictors of Melanoma prognosis in the United …

- jhu.edu [PDF] 
MJ Eide, MA Weinstock, MA Clark - Journal of Health Care for the Poor …, 2009 - muse.jhu.edu
Abstract: Studies suggest sociodemographic factors may influence melanoma prognosis. Our
objective was to quantify sociodemographic predictors of US melanoma. Data from 17,702 melanoma
cases reported to the Surveillance Epidemiology and End Results (SEER) program from ...
Cited by 2 - Related articles - All 5 versions

Pharmacogenomic dosing of warfarin: ready or not?


TE Lackner - The Consultant pharmacist: the journal of the American …, 2008 - ncbi.nlm.nih.gov
Warfarin is a medication with a narrow therapeutic index, nonlinear intrapatient
pharmacokinetics, and high interpatient variability in its dose-response relationship. These characteristics
create great difficulty in determining an appropriate dose; sub- or supratherapeutic doses ...
Cited by 2 - Related articles

Psychosocial aspects of DNA testing for hereditary hemochromatosis in at-risk …


J Picot, J Bryant, K Cooper, A Clegg, P … - Genetic Testing and …, 2009 - liebertonline.com
Aim: To review the psychosocial benefits and harms of DNA testing for HFE-related hereditary
hemochroma- tosis (HH) in at-risk individuals. Background: HH is a common genetic disease
in people of European descent. DNA-based predisposition testing is used for diagnosis or ...
Cited by 3 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google